Jocil Ltd’s Valuation Shifts to Very Expensive Amid Mixed Market Returns

Valuation Metrics Reflect Elevated Price Levels

Jocil’s current P/E ratio stands at 17.71, a figure that has contributed to its reclassification from expensive to very expensive in valuation terms. This is particularly striking when compared to its peer group within the Chemicals & Petrochemicals industry. For instance, J.G. Chemicals trades at a P/E of 31.94 but is rated as fairly valued, while Oriental Aromatics commands an astronomical P/E of 341.6, reflecting a different market perception. Other peers such as I G Petrochems and Titan Biotech also fall into the very expensive category with P/E ratios of 22.05 and 49.26 respectively.

Interestingly, Jocil’s price-to-book value ratio is currently 0.70, which is relatively low and might suggest undervaluation on a book basis. However, this metric alone does not offset the elevated P/E and enterprise value multiples, which investors often prioritise for growth and profitability assessment.

Enterprise Value Multiples and Profitability Ratios

Examining enterprise value (EV) multiples, Jocil’s EV to EBITDA ratio is 8.95, which is lower than many peers such as Titan Biotech (39.49) and Indo Borax & Chemicals (27.56), indicating a more moderate valuation on an operational earnings basis. However, the EV to EBIT ratio of 13.92 and EV to capital employed at 0.68 suggest mixed signals about operational efficiency and capital utilisation.

Profitability metrics remain a concern. Jocil’s return on capital employed (ROCE) is a mere 0.66%, and return on equity (ROE) is 3.93%, both figures significantly below industry averages. These low returns highlight challenges in generating adequate profits from invested capital, which may justify the cautious stance reflected in the Hold rating.

Mojo Score and Grade Downgrade

The company’s Mojo Score currently stands at 58.0, a middling figure that aligns with the Hold grade assigned on 3 August 2026, down from a Buy rating previously. This downgrade reflects the deteriorating valuation attractiveness despite recent price gains. The micro-cap status of Jocil also adds to the risk profile, as smaller companies often face higher volatility and liquidity constraints.

Price Performance Versus Sensex and Sector Peers

Jocil’s stock has outperformed the Sensex over short-term periods in 2026, with a 10.45% gain over one week and 11.76% over one month, compared to Sensex declines of 1.75% and 3.81% respectively. Year-to-date, the stock has appreciated 13.30%, while the Sensex has fallen 9.55%. However, longer-term returns paint a less favourable picture. Over one year, the stock is marginally down by 0.24%, while the Sensex has declined 4.59%. Over three and five years, Jocil has underperformed significantly, with losses of 16.73% and 30.44% respectively, against Sensex gains of 19.25% and 36.20%. Even over a decade, the stock has declined 13.49%, while the Sensex surged 164.01%.

Comparative Valuation Context

When benchmarked against peers, Jocil’s valuation appears stretched relative to its financial performance. For example, TGV Sraac, rated attractive, trades at a P/E of 8.44 and EV to EBITDA of 3.85, with a PEG ratio of 0.46, indicating better growth prospects relative to price. Conversely, Oriental Aromatics’ extremely high P/E of 341.6 suggests market expectations of exceptional growth or speculative premium, which is not the case for Jocil.

Jocil’s PEG ratio of 0.03 is unusually low, which might indicate undervaluation relative to earnings growth, but this figure should be interpreted cautiously given the company’s low profitability and returns. The dividend yield of 2.13% provides some income cushion but is modest in the context of valuation concerns.

Investment Implications and Outlook

Investors considering Jocil Ltd must weigh the recent price appreciation against the backdrop of stretched valuation metrics and subdued profitability. The downgrade to Hold reflects a more cautious stance, signalling that while the stock is not unattractive outright, it no longer offers compelling value relative to risk. The micro-cap nature of the company adds to the volatility and liquidity considerations, which may deter risk-averse investors.

Given the sector’s cyclical nature and the company’s modest returns on capital, investors might prefer to monitor valuation trends closely and compare with peers offering stronger fundamentals or more attractive valuations.

Summary

Jocil Ltd’s recent valuation shift to very expensive, combined with a downgrade in its Mojo Grade to Hold, signals a changing landscape for investors in the Chemicals & Petrochemicals sector. While short-term price gains have outpaced the broader market, the company’s low profitability and mixed valuation multiples suggest caution. Investors should consider peer comparisons and longer-term performance trends before committing fresh capital.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today